SynthesisInfectious diseases of poverty2022

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review.

Jingjing Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.